Brompton Global Healthcare Income & Growth ETF

  • Management Style
    Active with Covered Calls
  • Closing Price (Apr 12, 2024)
    $8.50
  • NAV (Apr 11, 2024)
    $8.61
  • Distribution Rate (Apr 12, 2024)
    7.76%
  • ESG Score (1)
    B+

This ETF provides monthly distributions and the opportunity for capital gains through an investment in an actively managed portfolio of large-cap global Healthcare companies selected by Brompton, complemented by a proprietary covered call program. Our PM team first uses a top-down analysis to identify attractive sub-sectors. Rigorous fundamental analysis focuses the portfolio on global Healthcare companies which offer a combination of growth and value characteristics. The PMs then actively set the level of covered call writing, with the goal of optimizing distributable cash and total returns.

Why Invest In Healthcare?

  • Strong historical earnings growth and stable relative share performance
  • Under-represented sector in the Canadian equity market; global Healthcare equities provide diversification benefits
  • Long term trends are supportive of Healthcare equities

This ETF is for Investors who are:

  • Seeking stable monthly cash distributions
  • Seeking opportunity for capital appreciation and lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of healthcare companies directly
  • Can handle the ups and downs of the stock market

FUND FACTS

  • Ticker (CAD Hedged)
    HIG
  • CUSIP (CAD Hedged)
    11222T105
  • Outstanding (CAD Hedged) (Apr 12, 2024)
    6,094,891
  • Ticker (USD Unit)
    HIG.U
  • CUSIP (USD Unit)
    11222T204
  • Outstanding (USD Unit) (Apr 05, 2024)
    82,500
  • Inception Date (CAD Hedged)
    September 24, 2015
  • ETF Conversion Date (CAD Hedged)
    April 3, 2018
  • Inception Date (USD)
    September 24, 2015
  • Management Fee
    0.75%
  • Manager/Portfolio Manager
    Brompton Funds Limited
  • Auditor
    PricewaterhouseCoopers LLP
  • Custodian
    CIBC Mellon Trust Company
  • Transfer Agent
    TSX Trust Company
  • Eligibility
    All registered and non-registered accounts
  • Risk Rating
    Medium

Manager/Portfolio Manager

Brompton Funds, a division of Brompton Group which was founded in 2000, is an experienced investment fund manager with income focused investment solutions including TSX traded closed-end funds and exchange-traded funds. Brompton’s Portfolio Management team specializes in Canadian and global equity investments and is a leading manager of covered call writing strategies in Canada.

Brompton Global Healthcare Income & Growth ETF

Summary of Investment Portfolio as at March 31, 2024

Total Net Asset Value$55,794,000

Top 25 Holdings

% of Portfolio% of Net Asset Value
Merck & Co Inc.5.2%
Cencora Inc.5.1%
Eli Lilly and Co.4.7%
HCA Healthcare Inc.4.7%
Stryker Corp.4.6%
Mckesson Corp.4.6%
West Pharmaceutical Services Inc.4.6%
Vertex Pharmaceuticals Inc.4.6%
AstraZeneca PLC4.5%
AbbVie Inc.4.5%
Intuitive Surgical Inc.4.5%
Novo Nordisk A/S4.4%
Boston Scientific Corp.4.2%
UnitedHealth Group Inc.4.1%
Johnson & Johnson4.1%
GSK PLC4.1%
Cigna Group4.0%
Agilent Technologies Inc.3.9%
Dexcom Inc.3.9%
Cardinal Health Inc.3.7%
Zoetis Inc.3.7%
Gilead Sciences Inc.3.2%
EssilorLuxottica S.A.3.0%
Abbott Laboratories1.9%
Cash1.5%
Total101.3%
Performance NAV History

Growth of $10,000(1)

Annual Compound Returns(2)

YTD 1-Year 3-Year 5-Year 10-Year Since Inception(3) Since Inception(4) Since Inception(2)
Brompton Global Healthcare Income & Growth ETF - CAD Hedged 10.1% 13.9% 5.0% 6.4% 6.3% N.A.
Brompton Global Healthcare Income & Growth ETF - USD 10.2% 14.5% 5.2% N.A. N.A. 6.6%

Year-by-Year Returns

2023 2022 2021 2020 2019 2018 2017 2016 2015(5)
Brompton Global Healthcare Income & Growth ETF - CAD Hedged (1.5%) (14.3%) 24.1% 6.3% 22.0% 5.0% 11.2% (6.3%) 3.1%
Brompton Global Healthcare Income & Growth ETF - USD (0.9%) (14.4%) 24.0% 8.4% 7.2%(6) n.a. n.a. n.a. n.a.

Returns for Brompton Global Healthcare Income & Growth ETF are unaudited.

This webpage is for information purposes only and does not constitute an offer to sell or a solicitation to buy the securities referred to herein. The opinions contained in this report are solely those of Brompton Funds Limited (“BFL”) and are subject to change without notice. BFL makes every effort to ensure that the information has been derived from sources believed to be reliable and accurate. However, BFL assumes no responsibility for any losses or damages, whether direct or indirect which arise from the use of this information. BFL is under no obligation to update the information contained herein. The information should not be regarded as a substitute for the exercise of your own judgment. Please read the prospectus before investing.

Commissions, trailing commissions, management fees and expenses all may be associated with exchange-traded fund investments. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Please read the prospectus before investing. Exchange-traded funds are not guaranteed, their values change frequently and past performance may not be repeated.

Information contained on this webpage was published at a specific point in time. Upon publication, it is believed to be accurate and reliable, however, we cannot guarantee that it is complete or current at all times. Certain statements contained on this webpage constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed on this webpage and to other matters identified in public filings relating to the ETF, to the future outlook of the ETF and anticipated events or results and may include statements regarding the future financial performance of the ETF. In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.

Filter By Document Type:

Distributions

The actual breakdown of distributions for tax purposes will be provided to unitholders annually in March. This information will also be posted on the website as soon as it is available.

This information is of a general nature only and does not constitute legal or tax advice to any particular investor. Accordingly, prospective investors are advised to consult their own tax advisors with respect to their individual circumstances.

DRIP

Investors may elect to automatically reinvest their distributions in additional units of the Fund and realize the benefits of compound growth.

DRIP Plan

Tax Allocation

The following information is applicable to holders who, for the purposes of the Income Tax Act (Canada), are resident in Canada and hold trust units as capital property. If this is not the case, a tax advisor should be consulted.

Holders of trust units outside of a RRSP, DPSP, RRIF, RESP or TFSA should expect to receive a T3 slip from their investment dealer. T3 supplementary slips will indicate Investment Income in Box 26, Foreign Non-Business Income in Box 25, Capital Gains in Box 21 and Dividend Income in Box 23 and Box 49. Dividend income is subject to the standard gross up and federal dividend tax credit rules.

The return of capital component is a non-taxable amount that serves to reduce the adjusted cost base of the Fund units and is reported in Box 42.

Select a year
Record Date Payment Date Capital Gains Eligible Dividend Foreign Non- Business Income Foreign Non- Business Income Tax Paid Other Income Return of Capital Total Distribution
Mar 28, 2024 Apr 12, 2024 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500
Feb 29, 2024 Mar 14, 2024 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500
Jan 31, 2024 Feb 14, 2024 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500
Dec 29, 2023 Jan 15, 2024 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Nov 30, 2023 Dec 14, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Oct 31, 2023 Nov 14, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Sep 30, 2023 Oct 16, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Aug 31, 2023 Sep 15, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Jul 31, 2023 Aug 15, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Jun 30, 2023 Jul 17, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
May 31, 2023 Jun 14, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Apr 28, 2023 May 12, 2023 0.00000 0.00000 0.00000 0.00000 0.00000 0.05500 0.05500
Total 0.00000 0.00000 0.00000 0.00000 0.00000 0.49500 0.66000
News Releases From to Search

Subscribe for updates.

Discover our innovative product suite, hear from our portfolio managers, and receive market updates.